HIGD1AP13

Across TCGA pan-cancer cohorts, HIGD1AP13 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated HIGD1AP13 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher HIGD1AP13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated HIGD1AP13 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, KICH, and COAD are the cancer types where HIGD1AP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.217	0.622	<.001	144	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	60	view →
COAD	DFS	Tertile	All	0.203	0.793	<.001	54	view →
KIRP	OS	Tertile	All	0.147	0.709	<.001	51	view →
ESCA	DFS	Tertile	III,IV	0.724	0.262	.003	36	view →
UCEC	OS	Tertile	All	0.772	0.927	.024	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

HIGD1AP13–BLCA (DFS)

Open the BLCA breakdown →